Takeda Pharmaceutical Company Limited (TSE: 4502) announced on 8/19/18 that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial showed... read more
Takeda Pharmaceutical Company Limited (TSE: 4502) announced on 8/19/18 that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial showed... read more
Symberix announced on 10/18/18 has been awarded three Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH), entered into a Research Collaboration... read more
LNC Therapeutics announced on 10/15/18 that it has signed an exclusive license agreement with Cornell University (Ithaca, NY, USA) for its Christensenella patent family.
Christensenella is... read more
HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. (NYSE: ANTM) and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are... read more
Evotec AG (FSE: EVT) (XETRA: EVT) (OTC PINK: EVTCY) and Ferring Pharmaceuticals ("Ferring") today announced a strategic research alliance to discover and develop new small molecule therapies to... read more